CPC A61K 31/16 (2013.01) [A61K 9/0019 (2013.01); A61K 38/177 (2013.01); A61K 38/2013 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01)] | 5 Claims |
1. A method of treating cancer in a subject in need thereof, which comprises administering to the subject an effective amount of (1) β-alethine and (2) at least one immune modulator, wherein the at least one immune modulator is an anti-PD-1 antibody or antigen-binding fragment thereof, and wherein the cancer is melanoma or bladder cancer.
|